AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 4.20%143.260.7%$2270.00m
PFEPfizer Inc. 3.01%34.620.9%$1409.80m
MRKMerck & Co., Inc. 3.82%81.560.7%$1316.06m
ABBVAbbVie, Inc. 4.18%78.542.3%$1246.32m
BMYBristol-Myers Squibb Co. 2.34%58.231.0%$1145.70m
LLYEli Lilly & Co. 2.93%146.031.1%$877.97m
AZNAstraZeneca Plc 1.74%43.851.2%$293.76m
NVSNovartis AG 1.95%85.630.2%$282.74m
GSKGlaxoSmithKline Plc 1.47%38.080.2%$247.18m
NVONovo Nordisk A/S 1.90%59.650.1%$175.07m
SNYSanofi 1.30%45.180.2%$168.70m
FTSVForty Seven, Inc. 0.05%95.510.0%$141.10m
BHCBausch Health Cos., Inc. 5.52%15.670.0%$103.36m
RGENRepligen Corp. -0.16%96.507.1%$67.92m
RETAReata Pharmaceuticals, Inc. 2.06%137.423.4%$63.95m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.